Omega-3 polyunsaturated fatty acid supplementation for the management of exercise-induced bronchoconstriction: a systematic review and meta-analysis
Abstract
Background Omega-3 polyunsaturated fatty acid (PUFA) supplementation is often cited as a non-pharmacological strategy for the management of exercise-induced bronchoconstriction (EIB); however, evidence remains inconsistent. Methods We conducted a systematic review and meta-analysis in accordance with PRISMA guidelines to evaluate the efficacy of omega-3 PUFA for the management of EIB. Studies including adults with EIB receiving omega-3 PUFA supplementation (eicosapentaenoic acid [EPA] and docosahexaenoic acid [DHA]) compared with placebo were included. The primary outcome was the post-challenge decline in FEV 1 following indirect bronchial provocation. Random-effects meta-analysis was performed using standardised mean differences (SMD) with 95% CIs. Results Eight studies (n=141 adults with EIB) met the inclusion criteria, of which six were included in the meta-analysis (n=106). Omega-3 PUFA supplementation was associated with attenuation of the post-challenge decline in FEV 1 (SMD=−0.96, [95% CI: −1.84 to −0.08]); however, substantial heterogeneity was observed (I 2 =87%), and the pooled estimate should therefore be interpreted with caution. Subgroup analyses demonstrated a greater apparent effect in studies employing exercise challenge (SMD=−1.54, [95% CI: −3.55 to −0.48]) compared with eucapnic voluntary hyperpnoea (SMD=−0.60, [95% CI: −1.31 to 0.12]). Conclusions Omega-3 PUFA supplementation does not provide a consistent clinical benefit in EIB. While modest attenuation of airway narrowing is reported in some cohorts, effects are heterogeneous and not reproducible. Where benefit is observed, it appears to coincide with suppression of lipid-derived inflammatory mediators, suggesting a potential endotype-specific mechanism. These findings indicate limited utility in unselected populations and support further precision-based trials.
Related
- Exercise-Induced Dehydration Limits the Effectiveness of Post-Exercise Whey Protein Supplementation in Healthy Young Men
- Effects of exercise on cognitive function in older adults: a systematic review and meta-analysis of the mediating role of sleep
- Is plant-based protein supplementation as effective as whey protein? A systematic review and meta-analysis in untrained adults undergoing resistance training.
- The effects of zinc supplementation on olfactory disorders: a systematic review with meta-analysis
- Effects of creatine supplementation on lean mass, muscle size and muscle performance during immobilisation and rehabilitation: A systematic review.
BibTeX
@article{thompson2026omega3,
title = {{Omega-3 polyunsaturated fatty acid supplementation for the management of exercise-induced bronchoconstriction: a systematic review and meta-analysis}},
author = {Christopher Thompson and Joe Sails and Rebecca J Birch and Julie Stang and Valérie Bougault and Matteo Bonini and Vibeke Backer and James H Hull and John D Brannan and Oliver J Price},
journal = {ERJ Open Research},
year = {2026},
month = aug,
doi = {10.1183/23120541.00729-2026},
url = {https://hal.science/hal-05732387v1},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Omega-3 polyunsaturated fatty acid supplementation for the management of exercise-induced bronchoconstriction: a systematic review and meta-analysis
AU - Christopher Thompson
AU - Joe Sails
AU - Rebecca J Birch
AU - Julie Stang
AU - Valérie Bougault
AU - Matteo Bonini
AU - Vibeke Backer
AU - James H Hull
AU - John D Brannan
AU - Oliver J Price
PY - 2026
DA - 2026/08/31
JO - ERJ Open Research
DO - 10.1183/23120541.00729-2026
UR - https://hal.science/hal-05732387v1
AB - Background Omega-3 polyunsaturated fatty acid (PUFA) supplementation is often cited as a non-pharmacological strategy for the management of exercise-induced bronchoconstriction (EIB); however, evidence remains inconsistent. Methods We conducted a systematic review and meta-analysis in accordance with PRISMA guidelines to evaluate the efficacy of omega-3 PUFA for the management of EIB. Studies including adults with EIB receiving omega-3 PUFA supplementation (eicosapentaenoic acid [EPA] and docosahexaenoic acid [DHA]) compared with placebo were included. The primary outcome was the post-challenge decline in FEV 1 following indirect bronchial provocation. Random-effects meta-analysis was performed using standardised mean differences (SMD) with 95% CIs. Results Eight studies (n=141 adults with EIB) met the inclusion criteria, of which six were included in the meta-analysis (n=106). Omega-3 PUFA supplementation was associated with attenuation of the post-challenge decline in FEV 1 (SMD=−0.96, [95% CI: −1.84 to −0.08]); however, substantial heterogeneity was observed (I 2 =87%), and the pooled estimate should therefore be interpreted with caution. Subgroup analyses demonstrated a greater apparent effect in studies employing exercise challenge (SMD=−1.54, [95% CI: −3.55 to −0.48]) compared with eucapnic voluntary hyperpnoea (SMD=−0.60, [95% CI: −1.31 to 0.12]). Conclusions Omega-3 PUFA supplementation does not provide a consistent clinical benefit in EIB. While modest attenuation of airway narrowing is reported in some cohorts, effects are heterogeneous and not reproducible. Where benefit is observed, it appears to coincide with suppression of lipid-derived inflammatory mediators, suggesting a potential endotype-specific mechanism. These findings indicate limited utility in unselected populations and support further precision-based trials.
SN - 2312-0541
ER -